Virios Therapeutics Inc

Research Virios Therapeutics Inc (DWTX) on Bullrun: market cap USD 59.86M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerDWTX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 59.86M
• Financial periodFY2025
• Net income-USD 34.26M

Valuation Snapshot

latest market cap is USD 59.86M.

About Virios Therapeutics Inc

Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, which is in Phase 2b clinical trial for the treatment of chemotherapy-induced neuropathic pain and cancer pain, as well as pre-clinical trial for acute surgical pain;

Frequently asked questions

What is Virios Therapeutics Inc's market cap?

Virios Therapeutics Inc's market capitalization is USD 59.86M.

What does Virios Therapeutics Inc do?

Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders.